Home/Filings/4/0001209191-20-051734
4//SEC Filing

Rosenberg Noah L. 4

Accession 0001209191-20-051734

CIK 0001438533other

Filed

Sep 22, 8:00 PM ET

Accepted

Sep 23, 8:00 PM ET

Size

5.0 KB

Accession

0001209191-20-051734

Insider Transaction Report

Form 4
Period: 2020-09-23
Rosenberg Noah L.
Chief Medical Officer
Transactions
  • Sale

    Common Stock

    2020-09-23$18.48/sh750$13,86027,555 total
Footnotes (1)
  • [F1]The sales reported in this Form 4 were made pursuant to a written plan meeting the requirements of Rule 10b5-1(c) of the Securities Exchange Act of 1934, as amended, and includes the sale of shares to cover the tax obligation that occurred upon the vesting of performance restricted stock units.

Issuer

Retrophin, Inc.

CIK 0001438533

Entity typeother

Related Parties

1
  • filerCIK 0001579649

Filing Metadata

Form type
4
Filed
Sep 22, 8:00 PM ET
Accepted
Sep 23, 8:00 PM ET
Size
5.0 KB